Entera Bio Cash Flow Statement (2019-2026) | ENTX

Cash Flow Statement Jun2019 Jun2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.44M-3.02M-2.36M-2.62M-2.73M-3.43M-3.14M-3.61M
Depreciation and Depletion (Quarter)
0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based Compensation (Quarter)
0.62M0.63M0.37M0.96M0.70M0.11M0.48M0.52M0.47M0.38M0.32M0.46M0.60M0.93M0.57M0.60M0.51M0.93M0.71M0.67M
Deferred Taxes (Quarter)
-0.06M-0.06M-0.05M-0.03M-0.03M0.21M0.02M0.03M0.01M
Cash from Operations (Quarter)
-2.12M-2.11M-2.51M-4.79M-2.83M-2.87M-2.01M-1.61M-1.56M-1.52M-2.62M-1.86M-1.33M-2.15M-1.47M-1.40M-1.63M-2.50M-1.83M-3.09M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables (Quarter)
0.10M0.14M-0.07M0.03M0.01M0.01M0.01M-0.22M-0.03M0.06M0.08M-0.01M
Change in Account Payables (Quarter)
-0.15M0.04M-0.16M0.03M-0.09M0.30M-0.40M0.13M0.09M0.32M-0.48M-0.02M0.00M0.12M-0.05M0.00M0.25M-0.17M0.23M-0.17M
Change in Accured Expenses (Quarter)
0.03M0.23M1.10M-0.81M-0.58M-0.76M0.58M0.06M0.19M-0.15M-0.66M0.03M0.17M-0.30M0.31M0.89M0.03M-0.08M0.20M-0.00M
Other Working Capital Changes (Quarter)
-0.17M-0.40M-0.20M1.10M-0.40M-0.32M-0.34M0.36M-0.00M-0.24M-0.17M0.32M-0.09M-0.19M-0.03M0.33M-0.08M-0.03M0.01M0.09M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.01M0.02M0.02M0.00M0.00M0.01M0.00M0.01M0.00M0.01M0.03M0.04M0.03M
Cash from Investing Activities (Quarter)
-0.01M-0.01M-0.02M-0.02M-0.06M-0.00M-0.01M-0.00M-0.01M-0.00M-0.01M-0.03M-0.04M-0.03M
Financing Activities
Other financing activities (Quarter)
6.61M0.03M0.56M0.01M0.09M0.15M0.02M0.18M0.15M0.13M
Cash from Financing Activities (Quarter)
12.67M2.58M0.02M0.01M0.01M6.03M0.03M1.22M0.01M3.22M13.34M-0.05M0.25M0.17M0.13M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
9.48M2.46M0.62M3.34M6.18M0.07M
Additional items
Exchange Rate Effect (Quarter)
-0.07M0.00M
Change in Cash (Quarter)
10.54M0.47M-2.50M-4.82M-2.83M-2.93M-2.01M-1.62M-1.55M-1.52M3.41M-1.83M-0.12M-2.14M1.75M11.93M-1.71M-2.29M-1.72M-2.96M
Free Cash Flow (Quarter)
-2.12M-2.12M-2.52M-4.82M-2.85M-2.87M-2.01M-1.62M-1.56M-1.52M-2.62M-1.86M-1.33M-2.15M-1.47M-1.41M-1.66M-2.54M-1.86M-3.09M
Net Cash Flow (Quarter)
10.54M0.47M-2.50M-4.82M-2.83M-2.93M-2.01M-1.62M-1.55M-1.52M3.41M-1.83M-0.12M-2.14M1.75M11.93M-1.71M-2.29M-1.69M-2.96M